MedTrace Logo

Abdominal Wall Closure After Laparotomy in Oncologic Surgery

NCT05041530 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-12-27

No results posted yet for this study

Summary

The REBUILD Study is a first-in-human evaluation of the safety and performance of REBUILD Bioabsorbable.

Conditions

  • Laparotomy

Interventions

DEVICE

REBUILD Bioabsorbable

REBUILD is an investigational medical device designed to be used with third-party suture to distribute suture tension in abdominal wall closures.

Sponsors & Collaborators

  • Cogent Technologies Corporation

    collaborator UNKNOWN

  • AbSolutions Med Inc.

    lead INDUSTRY

Principal Investigators

  • Luis J Palacios Fuenmayor, MD · Clinica Las Americas

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-17
Primary Completion
2023-03-31
Completion
2023-06-30
FDA Device
Yes

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05041530 on ClinicalTrials.gov